{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:59:45Z","timestamp":1772121585086,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["ILP-HSR-2019-006"],"award-info":[{"award-number":["ILP-HSR-2019-006"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004426","name":"Atlantic Philanthropies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018754","name":"An Roinn Sl\u00e1inte","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018754","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.sapharm.2025.05.012","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T02:53:21Z","timestamp":1747882401000},"page":"823-830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modelling the impact of changes to prescription medicine cost-sharing schemes among middle aged and older adults"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4339-5623","authenticated-orcid":false,"given":"James","family":"Larkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciaran","family":"Prendergast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logan T.","family":"Murry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Flood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Clyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conor","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Boland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Fahey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nav","family":"Persaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose Anne","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9838-3625","authenticated-orcid":false,"given":"Frank","family":"Moriarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.sapharm.2025.05.012_bib1","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999-2012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.sapharm.2025.05.012_bib2","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/pds.3947","article-title":"Increasing use of prescription drugs in the United Kingdom","volume":"25","author":"Zhang","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.sapharm.2025.05.012_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13942","article-title":"Polypharmacy and excessive polypharmacy in community\u2010dwelling middle aged and aged adults between 2011 and 2015","volume":"75","author":"Hellemans","year":"2021","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.sapharm.2025.05.012_bib4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3389\/fphar.2020.00326","article-title":"An increasing trend in the prevalence of polypharmacy in Sweden: a nationwide register-based study","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.sapharm.2025.05.012_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214240","article-title":"Trends in polypharmacy and dispensed drugs among adults in The Netherlands as compared to the United States","volume":"14","author":"Oktora","year":"2019","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.sapharm.2025.05.012_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008656","article-title":"Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study","volume":"5","author":"Moriarty","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.sapharm.2025.05.012_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/164_2019_301","article-title":"Why are new drugs expensive and how can they stay affordable?","author":"Hammel","year":"2019","journal-title":"Concepts Principles of Pharmacology: 100 Years of the Handbook of Experimental Pharmacology"},{"issue":"1","key":"10.1016\/j.sapharm.2025.05.012_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2017-000505","article-title":"Multimorbidity and out-of-pocket expenditure on medicines: a systematic review","volume":"3","author":"Sum","year":"2018","journal-title":"BMJ Glob Health"},{"issue":"9","key":"10.1016\/j.sapharm.2025.05.012_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-060502","article-title":"What is the impact of multimorbidity on out-of-pocket healthcare expenditure among community-dwelling older adults in Ireland? A cross-sectional study","volume":"12","author":"Larkin","year":"2022","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.sapharm.2025.05.012_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1071\/PY12035","article-title":"Multimorbidity is associated with higher out-of-pocket spending: a study of older Australians with multiple chronic conditions","volume":"19","author":"McRae","year":"2013","journal-title":"Aust J Prim Health"},{"key":"10.1016\/j.sapharm.2025.05.012_bib11","first-page":"1","article-title":"Can people afford to pay for health care? New evidence on financial protection in Ireland","author":"Johnston","year":"2020","journal-title":"Eurohealth"},{"issue":"10","key":"10.1016\/j.sapharm.2025.05.012_bib12","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.healthpol.2019.08.002","article-title":"Private health expenditure in Ireland: assessing the affordability of private financing of health care","volume":"123","author":"Johnston","year":"2019","journal-title":"Health Policy"},{"issue":"5","key":"10.1016\/j.sapharm.2025.05.012_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064914","article-title":"The effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations; a systematic review and meta-analysis","volume":"8","author":"Sinnott","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.sapharm.2025.05.012_bib20","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s11606-007-0180-x","article-title":"Patients at-risk for cost-related medication nonadherence: a review of the literature","volume":"22","author":"Briesacher","year":"2007","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10.1016\/j.sapharm.2025.05.012_bib21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/hex.13166","article-title":"The experience of financial burden for people with multimorbidity: a systematic review of qualitative research","volume":"24","author":"Larkin","year":"2020","journal-title":"Health Expect"},{"key":"10.1016\/j.sapharm.2025.05.012_bib22","unstructured":"Connors J. Staff Paper 2016 General Medical Services Scheme. Department of Public Expenditure and Reform. Accessed 23 July, 2024. https:\/\/assets.gov.ie\/181485\/424a462d-ed78-4438-bdd2-850e3dbecd16.pdf."},{"key":"10.1016\/j.sapharm.2025.05.012_bib23","series-title":"Challenges in Achieving Universal Healthcare in Ireland","author":"Wren","year":"2016"},{"key":"10.1016\/j.sapharm.2025.05.012_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.12688\/hrbopenres.13622.2","article-title":"Eligibility rates and representativeness of the General Medical Services scheme population in Ireland 2016-2021: a methodological report","volume":"5","author":"Mattsson","year":"2023","journal-title":"HRB Open Research"},{"key":"10.1016\/j.sapharm.2025.05.012_bib26","unstructured":"Belloni A MD, Paris V. Pharmaceutical Expenditure And Policies Past Trends And Future Challenges. OECD Health Working Papers No. 87. Accessed 29 July, 2024. https:\/\/www.oecd-ilibrary.org\/docserver\/5jm0q1f4cdq7-en.pdf?expires=1722264937&id=id&accname=guest&checksum=4B0E9898A03C56F8A1B1DE0850333625."},{"issue":"10020","key":"10.1016\/j.sapharm.2025.05.012_bib27","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(15)60002-2","article-title":"Moving towards universal health coverage: lessons from 11 country studies","volume":"387","author":"Reich","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.sapharm.2025.05.012_bib28","year":"2016"},{"issue":"5","key":"10.1016\/j.sapharm.2025.05.012_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyy163","article-title":"Cohort profile update: the Irish longitudinal study on ageing (TILDA)","volume":"47","author":"Donoghue","year":"2018","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.sapharm.2025.05.012_bib30","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s12877-022-03279-x","article-title":"Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis","volume":"22","author":"Delara","year":"2022","journal-title":"BMC Geriatr"},{"issue":"11","key":"10.1016\/j.sapharm.2025.05.012_bib32","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/gerona\/glx251","article-title":"What is the impact of physical activity and physical function on the development of multimorbidity in older adults over time? A population-based cohort study","volume":"73","author":"Ryan","year":"2018","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.sapharm.2025.05.012_bib33","article-title":"Out-of-pocket prescription medicine expenditure amongst community-dwelling adults: findings from the Irish longitudinal study on ageing (TILDA) in 2016","volume":"2025\/01\/20","author":"Larkin","year":"2025","journal-title":"Exploratory Research in Clinical and Social Pharmacy"},{"issue":"1","key":"10.1016\/j.sapharm.2025.05.012_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1377\/hlthaff.28.1.15","article-title":"Rising out-of-pocket spending for chronic conditions: a ten-year trend","volume":"28","author":"Paez","year":"2009","journal-title":"Health Aff"},{"issue":"1","key":"10.1016\/j.sapharm.2025.05.012_bib35","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12913-021-06446-9","article-title":"Effect of multimorbidity on utilisation and out-of-pocket expenditure in Indonesia: quantile regression analysis","volume":"21","author":"Anindya","year":"2021","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"10.1016\/j.sapharm.2025.05.012_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004694","article-title":"Examining different measures of multimorbidity, using a large prospective cross-sectional study in Australian general practice","volume":"4","author":"Harrison","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.sapharm.2025.05.012_bib39","article-title":"Citizens information","year":"2013","journal-title":"Budget"},{"key":"10.1016\/j.sapharm.2025.05.012_bib41","unstructured":"Citizens Information. Drugs Payment Scheme. Accessed 11 November, 2024. https:\/\/www.citizensinformation.ie\/en\/health\/drugs-and-medicines\/drugs-payment-scheme\/."},{"issue":"1","key":"10.1016\/j.sapharm.2025.05.012_bib44","first-page":"1","article-title":"Analyzing health care costs: a comparison of statistical methods motivated by Medicare colorectal cancer charges","volume":"1","author":"Griswold","year":"2004","journal-title":"Biostatistics (Oxf)"},{"issue":"8","key":"10.1016\/j.sapharm.2025.05.012_bib45","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/hec.1653","article-title":"Review of statistical methods for analysing healthcare resources and costs","volume":"20","author":"Mihaylova","year":"2011","journal-title":"Health Econ"},{"issue":"6","key":"10.1016\/j.sapharm.2025.05.012_bib46","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/pds.3917","article-title":"Copayments for prescription medicines on a public health insurance scheme in Ireland","volume":"25","author":"Sinnott","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.sapharm.2025.05.012_bib48","series-title":"Changes in Public Healthcare Entitlement and Healthcare Utilisation Among the Older Population in Ireland","author":"Nolan","year":"2016"},{"issue":"5","key":"10.1016\/j.sapharm.2025.05.012_bib49","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.sapharm.2025.05.012_bib50","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1002\/hpm.2458","article-title":"How and why do countries differ in their governance and financing\u2010related administrative expenditure in health care? An analysis of OECD countries by health care system typology","volume":"33","author":"Hagenaars","year":"2018","journal-title":"Int J Health Plann Manag"},{"issue":"1","key":"10.1016\/j.sapharm.2025.05.012_bib51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00002512-200825010-00008","article-title":"Accuracy of telephone self-report of drug use in older people and agreement with pharmaceutical claims data","volume":"25","author":"Pit","year":"2008","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.sapharm.2025.05.012_bib52","first-page":"3","article-title":"Comparability of self-reported medication use and pharmacy claims data","volume":"24","author":"Allin","year":"2013","journal-title":"Health Rep"},{"key":"10.1016\/j.sapharm.2025.05.012_bib53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2307\/3350095","article-title":"Recall strategies and memory for health-care visits","author":"Jobe","year":"1990","journal-title":"Milbank Q"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741125002554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741125002554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:26:53Z","timestamp":1762550813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741125002554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1551741125002554"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.05.012","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.01.21.25320791","asserted-by":"object"}]},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modelling the impact of changes to prescription medicine cost-sharing schemes among middle aged and older adults","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}